Vital Signs - In Acquisitions We Trust

Vital Signs - In Acquisitions We Trust

 

RELEASE DATE
12-Feb-2007
REGION
North America
Research Code: 9561-00-26-00-00
SKU: HC00470-NA-MR_03942
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00470-NA-MR_03942
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on February 12, 2007, provides a strategic overview of important acquisition criteria for M&A activities in the pharmaceutical industry. Additionally, an emerging company profile is provided for AmpliMed Corporation, a clinical stage pharmaceutical company specializing in small molecule oncology drugs. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of January 29 - February 2, 2007.

Table of Contents

Related Research
This issue of Vital Signs, released on February 12, 2007, provides a strategic overview of important acquisition criteria for M&A activities in the pharmaceutical industry. Additionally, an emerging company profile is provided for AmpliMed Corporation, a clinical stage pharmaceutical company specializing in small molecule oncology drugs. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of January 29 - February 2, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-26-00-00
Is Prebook No